COVID-19 Vaccine
PreclinicalCompleted 0 views this week 0 watching
0
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Coronavirus Disease (COVID-19)
Conditions
Coronavirus Disease (COVID-19)
Trial Timeline
Dec 22, 2021 → Apr 28, 2023
NCT ID
NCT04941144About COVID-19 Vaccine
COVID-19 Vaccine is a preclinical stage product being developed by Moderna for Coronavirus Disease (COVID-19). The current trial status is completed. This product is registered under clinical trial identifier NCT04941144. Target conditions include Coronavirus Disease (COVID-19).
What happened to similar drugs?
0 of 12 similar drugs in Coronavirus Disease (COVID-19) were approved
Approved (0) Terminated (2) Active (10)
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04941144 | Preclinical | Completed |
Competing Products
20 competing products in Coronavirus Disease (COVID-19)